CHIRON CORPORATION

1545 US Highway 22 E, Annandale, New Jersey, United Stateswww.chiron.com5,400 employeesEstablished: 1981-01-01

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

1981

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

45.5%

Phase 1

36.4%

Not Applicable

9.1%

Phase 4

9.1%

Trial Status Distribution

Completed

63.6%

Terminated

18.2%

Unknown

18.2%

Clinical Trials

Trials sponsored by this organization (11)

Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer

Kinetic of Immune Memory Response After Re-Vaccination With Meningococcal Vaccine

Phase 4

Unknown

interventional

Sep 2003264 participants

Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal Cancer

Safety and Effectiveness of L2-7001 (Interleukin-2) in HIV-Positive Patients Receiving Anti-HIV Therapy

Phase 1

Unknown

interventional

Aug 1999212 participants

A Phase I, Observer-Blind, Placebo-Controlled Study of the Chiron Vaccine HIV p24/MF59 Administered to Healthy HIV-Seronegative Adults

Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine or Dideoxyinosine in HIV Positive, Asymptomatic and Symptomatic Individuals

Not Applicable

Completed

interventional

A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis

Phase 1

Completed

interventional

Comparing Interleukin-2 (IL-2) Combined With Rituximab (Rituxan) to Rituximab Alone in Subjects With Non-Hodgkin's Lymphoma (NHL)

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations